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ABSTRACT - This study describes preliminary laryngeal electromyography (LEMG) data and botulinum tox-
in treatment in patients with dysphonia due to movement disorders. Twenty-five patients who had been
clinically selected for botulinum toxin administration were examined, 19 with suspected laryngeal dysto-
nia or spasmodic dysphonia (SD), 5 with vocal tremor, and 1 with Gilles de la Tourette syndrome (GTS). LEMG
evaluations were performed before botulinum toxin administration using monopolar electrodes.
Electromyography was consistent with dystonia in 14 patients and normal in 5, and differences in frequen-
cy suggesting essential tremor in 3 and Parkinson tremors in 2. The different LEMG patterns and signifi-
cant improvement in our patients from botulinum toxin therapy has led us to perform laryngeal electromyo-
graphy as a routine in UNICAMP movement disorders ambulatory.
KEY WORDS: laryngeal electromyography, movement disorders, botulinum toxin.
Eletromiografia laríngea e distúrbios do movimento: dados preliminares
RESUMO - Este estudo descreve dados preliminares de eletromiografia laríngea (LEMG) e tratamento com
toxina botulínica em pacientes com disfonia associada a distúrbios do movimento. Foram estudados 25
pacientes, 19 com distonia laríngea ou disfonia espasmódica, 5 com tremor vocal e 1 com síndrome de Gilles
de la Tourette. LEMG realizada com eletrodos monopolares, antes da administração de toxina botulínica,
foi compatível com distonia em 14 pacientes (normal em 5), sugeriu tremor essencial em 3 e Parkinson em
2. Os diferentes padrões de LEMG e  melhora considerável obtida com administração de toxina botulínica
instituíram LEMG como rotina no ambulatório  de distúrbios do movimento da UNICAMP.
PALAVRAS-CHAVE: eletromiografia, laringe, toxina botulínica.
Dysphonia is a speech problem caused by abnor-
malities in the sound generator, such as laryngeal
structures1. The production of sound requires fine
and precise motor synchronism of the laryngeal
muscles; this is often affected in movement disor-
der patients1. Laryngeal electromyography (LEMG)
is a useful diagnostic method for motor unit disor-
ders2-8; it can be used to establish the cause of
laryngeal immobility9-11 and help guide the needle
to the correct location for botulinum toxin adminis-
tration in laryngeal hyperkinetic movement disor-
der patients12-14.
We describe preliminary LEMG pattern data
from 25 patients complaining of dysphonia attend-
ing UNICAMP movement disorders ambulatory
whose clinical examinations and laryngeal endosco-
pies suggested vocal fold hyperkinetic movement
disorders. 
METHOD
A total of 25 patients complaining of dysphonia we-
re seen at UNICAMP movement disorders and laryngol-
ogy ambulatories between January 2000 and January
2003. After consent from the ethical medical commit-
tee for human research, all patients were submitted to
clinical and endoscopic evaluation, and selected for bo-
tulinum toxin treatment due to the diagnosis of hyperki-
netic vocal fold movement disorder. Patients with nor-
mal LEMG or Parkinson’s disease tremors were not treat-
ed with botulinum toxin.
LEMG was performed before botulinum toxin admin-
istration, with patient in seated position, slightly inclined
back support, head supported and slightly extended, arms
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hanging beside the body, and shoulders and cervical mus-
culature relaxed. 
Records were made using a four-channel Nihon Koh-
den Neuropack µ, with 112dB minimum common mode
rejection ratio, 0.6 µVrms noise level, and 1000 MΩ in-
put impedance. Filter band-pass was set to 10 - 10000
Hz, sensitivity to 200 µV/cm, and analysis time to 50 ms/cm.
After skin asepsia with alcohol, a monopolar electrode
was inserted by percutaneous technique for laryngeal
muscles approach13-15. The tireoaritenoideus muscle (TA)
was studied in all patients and cricoaritenoideus poste-
rioris muscle (CAP) in just 2 with abduction spasmodic
dysphonia (SD).
Botulinum toxin, 2.5U of BotoxR, diluted in 0.9% sa-
line solution was administered unilaterally in TA mus-
cle of all adduction SD patients, 3 with essential tremor
(ET), and 1 with Gilles de le Tourette Syndrome (GTS).
For 2 abduction SD patients, botulinum toxin was unila-
terally administered in CAP muscle. Botulinum toxin
was not administered in 2 patients with Parkinson tremor
or the 5 normal LEMG patients. The 0-10 scale of improve-
ment was used for treatment evaluation16. Improvement
was considered significant between 8-10, mild between
5-7, poor between 2-4, and insignificant or without im-
provement between 0-1.
RESULTS
Of the 25 patients, 18 were female and 7 male,
ages were between 21 and 86 years (mean 51.4).
Endoscopy and clinical examination were consistent
with SD in 19 patients, vocal tremor in 5, and GTS
in 1. LEMG results were consistent with SD in 14 (12
adduction and 2 abduction), normal in 5, vocal tre-
mor in 5 (3 essential tremor and 2 Parkinson), and
GTS in 1. Results are shown in Table 1.
All patients with adduction SD showed increased
TA muscle rest activity with irregular bursts dur-
ing muscle contraction. In abduction SD patients,
this abnormal muscle activity was found in CAP. Tre-
mor was not observed in SD patients. Essential
tremor was diagnosed in 3 patients with normal
TA activity at rest and rhythmic bursts of 8 - 11 Hz
muscle activity during sustained phonation. Tremor
was bilateral in these patients. The 2 patients with
Parkinson tremor had rhythmic bursts of 5-6 Hz
muscle activity at rest that disappeared with phona-
tion; one patient was unilateral on the right hand
side, the other bilateral. The GTS patient had spo-
radic subtle bursts of involuntary muscle activity
independent of voluntary phonation.
Botulinum toxin was administered to 18 pa-
tients: 14 with SD, 3 with essential tremor and 1 with
GTS. In 14 SD patients treated with botulinum to-
xin, 9 showed significant improvement, 3 mild, and
2 poor. The 2 patients with poor results had ab-
duction SD. In 3 patients with essential tremor, 1
showed significant improvement, the other 2 mild.
In the GTS patient improvement was significant.
DISCUSSION
The most common movement disorders affect-
ing laryngeal muscles were reviewed by Brin et al1.
They were classified as hypokinetic, hyperkinetic,
and mixed according to muscle abnormality1. LEMG
can help differentiate patterns in abnormal mus-
cle activity and identify the muscles to be treated
with botulinum toxin1,6,12-14,17.
Although tremor is the most common move-
ment disorder, the most frequent type of hyperki-
netic laryngeal movement disorder encountered
in our service is SD; this is similar to other authors1,6.
Spasmodic dysphonia patients commonly display
normal function at rest with abnormal involuntary
adductor (adduction SD) or abductor muscle (ab-
duction SD) co-activation during phonation1,6,17,18.
LEMG showed increased muscle activity in the ap-
parently normal muscles at rest; during phona-
tion co-activation manifested as bursts of adduc-
tor or abductor muscle activity.
In this study, as in literature, the SD group were
predominantly of adduction type1,12-14,17. Although
25 to 30 % of patients presented tremor1, no tre-
mor was found in our SD patients. In the past SD
was thought to be a psychogenic disorder, but
Aronson18,19 reported no difference between SD pa-
tients and normal subjects using psychiatric tests.
Interestingly we found 5 patients with mildly eleva-
ted rest activity in TA muscles which was interpre-
ted as psychogenic dysphonia. Brin et al.1 consid-
ered psychogenic dystonia as a form of secondary
dystonia with dystonic phenomenology and psy-
chiatric etiology. They also considered it a rare con-
dition because patients were referred to a psychi-
atrist and not a movement disorders service. We
suggested speech therapy to our patients before
any other type of treatment. In accordance with
many authors1,12-14,17 the majority of our SD patients
showed improvement after botulinum toxin admin-
istration; results were poor in abduction SD. Brin
et al.14 reported an average of 50% improvement
in abduction SD patients.
Tremor is a rhythmic oscillatory movement, such
as in the laryngeal sound generator, with relative-
ly stable periodicity1,20,21. After Ardran et al.22, oth-
er authors have studied vocal tremor using
LEMG1,19,23. In ET patients, LEMG generally shows
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Table 1. LEMG findings and botulinum toxin treatment in patients with movement disorders.
Case Sex Age Diagnosis  LEMG findings Improvement
before LEMG with BotoxR
(2,5U)
1 F 58 SD adduction Increased TA rest activity. Bursts with phonation 8
2 F 57 SD adduction Increased TA rest activity. Bursts with phonation 9
3 F 38 SD adduction Increased TA rest activity. Bursts with phonation 7
4 F 57 SD adduction Increased TA rest activity. Bursts with phonation 8
5 F 55 SD adduction Increased TA rest activity. Bursts with phonation 8
6 F 38 SD adduction Increased TA rest  activity. Bursts with phonation 8
7 F 48 SD adduction Increased TA rest activity. Bursts with phonation 10
8 F 73 SD adduction Increased TA rest activity. Bursts with phonation 5
9 F 67 SD adduction Increased TA rest activity. Bursts with phonation 7
10 F 59 SD adduction Increased TA rest activity. Bursts with phonation 8
11 F 38 SD abduction Increased CAP rest activity. Bursts with phonation 4
12 M 37 SD adduction Increased TA rest activity. Bursts with phonation 8
13 M 54 SD adduction Increased TA rest activity. Bursts with phonation 10
14 M 33 SD abduction Increased CAP rest activity. Bursts with phonation 2
15 F 21 SD adduction Increased TA rest activity with normal activity during phonation -
16 F 32 SD adduction Increased TA rest activity with normal activity during phonation -
17 M 38 SD adduction Increased TA rest activity with normal activity during phonation -
18 M 58 SD adduction Increased TA rest activity with normal activity during phonation -
19 M 25 SD adduction Increased TA rest activity with normal activity during phonation -
20 M 65 Vocal tremor (P) Rest:  5-6Hz rhythmic TA activity. Action: Normal -
21 F 69 Vocal tremor (P) Rest:  6Hz rhythmic TA activity.  Action: Normal -
22 F 70 Vocal tremor (ET) Rest: Normal Action: 9-11 Hz rhythmic TA activity. 8
23 F 81 Vocal tremor (ET) Rest: Normal Action: 8-9 Hz rhythmic TA activity. 4
24 F 86 Vocal tremor (ET) Rest: Normal Action: 10Hz rhythmic TA activity. 6
25 F 27 VocalTic (GTS) Subtle bursts of TA activity at rest or during phonation 8
SD, spasmodic dysphonia; TA, tireoaritenoideus muscle; CAP, cricoaritenoideus posterioris muscle; P, Parkinson; ET, essencial tremor; GTS, Gilles de la
Tourette syndrome.
normal activity at rest and 4-12 Hz muscle rhythm
tremor during sustained phonation23. The most
common EMG pattern in ET is agonist-antagonist
muscle co-activation24. In our patients there was a
higher frequency of muscle activity but the other
characteristics were similar. According to Brin et
al.1,14, treatment with botulinum toxin showed
mild to significant improvement in all our patients. 
In Parkinson’s disease, vocal tremors are seen
as a 4-7 Hz rest rhythmic muscle activity25,26 simi-
lar to oral and jaw tremor27, which can oscillate25,26,
and disappear with phonation1. Tremor can be
unilateral in Parkinson’s disease1 with the most
frequent EMG pattern being alternating agonist-
antagonist muscle activation24. Our 2 PD patients
showed similar characteristics. Botulinum toxin
was not administered in our patients at the time
of research, because speech therapy was suggest-
ed as the first treatment.
Tics are brief, purposeless, stereotyped and repe-
titive movements of muscle groups1,28. GTS, consid-
ered the most severe form of tic, may occur with vo-
 
cal tics1,28. No reports of LEMG that evaluated GTS
were found. Our only GTS patient presented sub-
tle bursts of TA activity at rest or during phonation. 
In all 25 patients motor unit action potentials
were of normal amplitude and duration.
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